ADXN
Price
$8.60
Change
-$0.18 (-2.05%)
Updated
Nov 13, 12:20 PM (EDT)
Capitalization
8.78M
Intraday BUY SELL Signals
ANVS
Price
$2.31
Change
-$0.12 (-4.94%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
59.8M
129 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ADXN vs ANVS

Header iconADXN vs ANVS Comparison
Open Charts ADXN vs ANVSBanner chart's image
Addex Therapeutics
Price$8.60
Change-$0.18 (-2.05%)
Volume$151
Capitalization8.78M
Annovis Bio
Price$2.31
Change-$0.12 (-4.94%)
Volume$404
Capitalization59.8M
ADXN vs ANVS Comparison Chart in %
ADXN
Daily Signal:
Gain/Loss:
ANVS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ADXN vs. ANVS commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADXN is a Hold and ANVS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (ADXN: $8.81 vs. ANVS: $2.43)
Brand notoriety: ADXN and ANVS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADXN: 2% vs. ANVS: 228%
Market capitalization -- ADXN: $8.78M vs. ANVS: $59.8M
ADXN [@Biotechnology] is valued at $8.78M. ANVS’s [@Biotechnology] market capitalization is $59.8M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADXN’s FA Score shows that 1 FA rating(s) are green whileANVS’s FA Score has 1 green FA rating(s).

  • ADXN’s FA Score: 1 green, 4 red.
  • ANVS’s FA Score: 1 green, 4 red.
According to our system of comparison, ADXN is a better buy in the long-term than ANVS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADXN’s TA Score shows that 3 TA indicator(s) are bullish while ANVS’s TA Score has 6 bullish TA indicator(s).

  • ADXN’s TA Score: 3 bullish, 6 bearish.
  • ANVS’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, ANVS is a better buy in the short-term than ADXN.

Price Growth

ADXN (@Biotechnology) experienced а +0.56% price change this week, while ANVS (@Biotechnology) price change was +19.12% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

ANVS is expected to report earnings on Mar 23, 2026.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANVS($59.8M) has a higher market cap than ADXN($8.78M). ADXN YTD gains are higher at: 25.857 vs. ANVS (-51.690). ADXN has higher annual earnings (EBITDA): -12.19M vs. ANVS (-23.68M). ANVS has more cash in the bank: 17.1M vs. ADXN (3.35M). ADXN has higher revenues than ANVS: ADXN (556K) vs ANVS (0).
ADXNANVSADXN / ANVS
Capitalization8.78M59.8M15%
EBITDA-12.19M-23.68M51%
Gain YTD25.857-51.690-50%
P/E RatioN/AN/A-
Revenue556K0-
Total Cash3.35M17.1M20%
Total Debt43.8KN/A-
TECHNICAL ANALYSIS
Technical Analysis
ADXNANVS
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 7 days ago
87%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ADXN
Daily Signal:
Gain/Loss:
ANVS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BBGI4.350.03
+0.69%
Beasley Broadcast Group Inc
WOR55.170.20
+0.36%
Worthington Enterprises
SNDA32.050.06
+0.19%
Sonida Senior Living
ILMN121.98-0.62
-0.51%
Illumina
EPSN4.90-0.12
-2.39%
Epsilon Energy Ltd

ADXN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADXN has been loosely correlated with ANVS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ADXN jumps, then ANVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADXN
1D Price
Change %
ADXN100%
N/A
ANVS - ADXN
43%
Loosely correlated
+15.17%
CVM - ADXN
39%
Loosely correlated
-4.80%
XRTX - ADXN
28%
Poorly correlated
-2.06%
KZIA - ADXN
25%
Poorly correlated
-0.78%
ARTV - ADXN
24%
Poorly correlated
+10.86%
More

ANVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANVS has been loosely correlated with ADXN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ANVS jumps, then ADXN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANVS
1D Price
Change %
ANVS100%
+15.17%
ADXN - ANVS
43%
Loosely correlated
N/A
RXRX - ANVS
38%
Loosely correlated
-1.27%
VYGR - ANVS
37%
Loosely correlated
-0.23%
BDTX - ANVS
37%
Loosely correlated
+5.41%
ATXS - ANVS
37%
Loosely correlated
+0.32%
More